Literature DB >> 21622105

C-Myb function in the vessel wall.

Kelly A Farrell1, Sarah B Withers, Cathy M Holt.   

Abstract

C-Myb is a DNA-binding transcription factor that functions in apoptosis, proliferation and differentiation. The role of c-Myb in vascular injury has been investigated previously both in vitro and in vivo, where knock-down of c-Myb is known to lead to a reduction in proliferation and an increase in apoptosis of vascular smooth muscle cells (VSMCs). Reduction of c-Myb activity has also been shown to decrease neointimal formation in vivo, by reducing VSMC proliferation. In contrast, over-expression of c-Myb in vivo leads to increased survival rates in certain cell types. This review will look mainly at studies investigating c-Myb function in the vasculature, and evidence of signalling interactions which may be considered with regard to c-Myb as a possible target in the treatment of vasculoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622105     DOI: 10.2741/e302

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  4 in total

1.  Variation of pathways and network profiles reveals the differential pharmacological mechanisms of each effective component to treat middle cerebral artery ischemia-reperfusion mice.

Authors:  HaiXia Dang; KangNing Li; YaNan Yu; YingYing Zhang; Jun Liu; PengQian Wang; Bing Li; HaiNan Wang; Haixia Li; Zhong Wang; YongYan Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-12

2.  Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.

Authors:  Debra A Schaumberg; Lynda Rose; Margaret M DeAngelis; Richard D Semba; Gregory S Hageman; Daniel I Chasman
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

Review 3.  Transcription Factors Targeted by miRNAs Regulating Smooth Muscle Cell Growth and Intimal Thickening after Vascular Injury.

Authors:  Levon M Khachigian
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

4.  MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease.

Authors:  Zheng-Rong Zhu; Qiong He; Wei-Bin Wu; Guang-Qi Chang; Chen Yao; Yang Zhao; Mian Wang; Shen-Ming Wang
Journal:  J Atheroscler Thromb       Date:  2018-05-11       Impact factor: 4.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.